LIA (Group I) n (%) | ACB (Group II) n (%) | ACB AND LIA (Group III) n (%) | p-value | ||||
---|---|---|---|---|---|---|---|
Group (I vs. 2) | Group (I vs. III) | Group (II vs. III) | ANOVA | ||||
Any Adverse effects | 13 (32.5) | 17 (42.5) | 9 (22.5) | 0.314 | 0.319 | 0.047 | 0.161 |
Nausea | 12 (30.0) | 11 (27.5) | 7 (17.5) | 0.806 | 0.192 | 0.287 | 0.393 |
Vomiting | 1 (2.5) | 6 (15.0) | 2 (5.0) | 0.049 | 0.559 | 0.138 | 0.080 |
Pruritus | None | None | None | – | – | – | – |
Fall | None | None | None | – | – | – | – |
Distal neuro- vascular deficit | None | None | None | – | – | – | – |
DVT | None | None | None | – | – | – | – |
Convulsion | None | None | None | – | – | – | – |
Cardiovascular Complications | None | None | None | – | – | – | – |